glp 1 liver function GLP-1 Receptor Agonist and Non-Alcoholic Fatty Disease Engineered GLP-1R-targeting nanoplatforms: multimodal therapeutics

Research demonstrates that women who lose weight through anti-obesity medications are frequently judged more harshly and perceived as having taken a shortcut to weight loss (Post and Persky, 2024)

According to Pfizer, nearly half of danuglipron users reported at least one gastrointestinal side effect, and 34% discontinued the medication because of a treatment-emergent adverse event

Through the analysis of numerous in vivo and in vitro studies aimed at determining the mechanisms by which GLP-1 enhances insulin secretion in individuals with normal glucose tolerance or T2DM, two main intracellular mechanisms underlying the incretin effect have emerged

In this study, 35 participants were randomly allocated to a lixisenatide (20 mg) group or once-daily insulin glulisine treatment group

Most headaches improve with hydration, dietary adjustments, and time